Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alex Spyropoulos and Mark Goldin.
Alex Spyropoulos
Connection Strength
3.371
Mark Goldin
  1. Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors. Res Pract Thromb Haemost. 2021 Jul; 5(5):e12547.
    View in: PubMed
    Score: 0.953
  2. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. J Thromb Thrombolysis. 2021 Nov; 52(4):1032-1035.
    View in: PubMed
    Score: 0.952
  3. Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Dec; 121(12):1684-1695.
    View in: PubMed
    Score: 0.938
  4. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021 05 20; 137(20):2838-2847.
    View in: PubMed
    Score: 0.237
  5. Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19. Res Pract Thromb Haemost. 2021 Feb; 5(2):296-300.
    View in: PubMed
    Score: 0.233
  6. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):897-901.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.